Suppr超能文献

细胞内在性CD4 T细胞耐受性:治疗新前沿?

Cell-intrinsic CD4 T cell tolerance: a new frontier in therapy?

作者信息

Cassano Alexandra, Abbondanza Domenic, Chong Anita S, Alegre Maria-Luisa

机构信息

Department of Medicine, University of Chicago, Chicago, IL, USA.

Department of Surgery, University of Chicago, Chicago, IL, USA.

出版信息

Trends Immunol. 2025 Jul 23. doi: 10.1016/j.it.2025.07.001.

Abstract

CD4 T cell tolerance is essential for immune homeostasis but its mechanisms remain unclear. Although regulatory T cells (Tregs) mediate T cell-extrinsic tolerance, this review emphasizes the CD4 T cell-intrinsic pathways - anergy and exhaustion - that are triggered by suboptimal or persistent antigen stimulation. These states share transcriptional and epigenomic features across contexts such as cancer, pregnancy, and transplantation. Instead of being distinct, they form a spectrum of tolerance with potential for therapeutic targeting. CD154 has re-emerged as a promising target, although memory T cell tolerization remains challenging. A deeper understanding of what sustains or reverses CD4 T cell tolerance is key to designing treatments that induce/maintain tolerance in autoimmunity and transplantation, or restore functionality in cancer and chronic infection.

摘要

CD4 T细胞耐受性对于免疫稳态至关重要,但其机制仍不清楚。尽管调节性T细胞(Tregs)介导T细胞外在耐受性,但本综述强调了由次优或持续抗原刺激引发的CD4 T细胞内在途径——无反应性和耗竭。这些状态在癌症、妊娠和移植等不同情况下具有共同的转录和表观基因组特征。它们并非截然不同,而是形成了一个具有治疗靶向潜力的耐受性谱。CD154已重新成为一个有前景的靶点,尽管记忆T细胞耐受性的诱导仍然具有挑战性。更深入地了解维持或逆转CD4 T细胞耐受性的因素,是设计在自身免疫和移植中诱导/维持耐受性,或在癌症和慢性感染中恢复功能的治疗方法的关键。

相似文献

1
Cell-intrinsic CD4 T cell tolerance: a new frontier in therapy?
Trends Immunol. 2025 Jul 23. doi: 10.1016/j.it.2025.07.001.
2
T-bet expressing Tr1 cells driven by dietary signals dominate the small intestinal immune landscape.
bioRxiv. 2025 Jul 4:2025.06.30.662190. doi: 10.1101/2025.06.30.662190.
4
Sepsis leads to lasting changes in phenotype and function of memory CD8 T cells.
Elife. 2021 Oct 15;10:e70989. doi: 10.7554/eLife.70989.
6
Type 1 Diabetes: A Guide to Autoimmune Mechanisms for Clinicians.
Diabetes Obes Metab. 2025 May 15. doi: 10.1111/dom.16460.
7
All-Cause Mortality and Specific Causes of Death in Autism: A Nationwide Analysis.
Autism Adulthood. 2025 Feb 5;7(1):81-92. doi: 10.1089/aut.2023.0103. eCollection 2025 Feb.
8
The Lived Experience of Autistic Adults in Employment: A Systematic Search and Synthesis.
Autism Adulthood. 2024 Dec 2;6(4):495-509. doi: 10.1089/aut.2022.0114. eCollection 2024 Dec.
10
Management of urinary stones by experts in stone disease (ESD 2025).
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.

本文引用的文献

1
T Cell Exhaustion in Allergic Diseases and Allergen Immunotherapy: A Novel Biomarker?
Curr Allergy Asthma Rep. 2025 Mar 17;25(1):18. doi: 10.1007/s11882-025-01199-5.
4
Low-avidity T cells drive endogenous tumor immunity in mice and humans.
Nat Immunol. 2025 Feb;26(2):240-251. doi: 10.1038/s41590-024-02044-z. Epub 2025 Jan 9.
5
PD-1 and CD73 on naive CD4 T cells synergistically limit responses to self.
Nat Immunol. 2025 Jan;26(1):105-115. doi: 10.1038/s41590-024-02021-6. Epub 2024 Nov 21.
7
Autoimmune CD4 T cells fine-tune TCF1 expression to maintain function and survive persistent antigen exposure during diabetes.
Immunity. 2024 Nov 12;57(11):2583-2596.e6. doi: 10.1016/j.immuni.2024.09.016. Epub 2024 Oct 12.
8
The renaissance of oral tolerance: merging tradition and new insights.
Nat Rev Immunol. 2025 Jan;25(1):42-56. doi: 10.1038/s41577-024-01077-7. Epub 2024 Sep 6.
9
Autoantigen-specific CD4 T cells acquire an exhausted phenotype and persist in human antigen-specific autoimmune diseases.
Immunity. 2024 Oct 8;57(10):2416-2432.e8. doi: 10.1016/j.immuni.2024.08.005. Epub 2024 Sep 2.
10
Post-immunotherapy CTLA-4 Ig treatment improves antitumor efficacy.
Proc Natl Acad Sci U S A. 2024 Jul 2;121(27):e2404661121. doi: 10.1073/pnas.2404661121. Epub 2024 Jun 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验